Page not found
Search results
-
Dr. James Crowe Jr. receives SEC Faculty Achievement Award
... have helped propel Vanderbilt’s role on the world stage in the development of treatments against COVID-19 and other devastating ... cited papers in leading scientific journals, including Cell , Science and in major medical journals such as NEJM and ...
sommers - 04/12/2021 - 10:53am
-
ASPIRE - Technology Commercialization - Session 4
... fields of work. This session will cover an overview of technology commercialization, including academic commercialization strategies, role of translational research, and early stage product development. As part of a federal grant, it is requested that ...
utleytj - 10/02/2015 - 10:45am
-
Tech Connect, Vol. 6, Issue 16: CTTC participates at AUTM 2016
... participates at AUTM 2016 Each year, thousands of technology transfer officers convene with professionals from a variety of ... partnering meetings with companies with interests in early stage university inventions. ...
steelmk - 11/10/2016 - 7:45am
-
Monoclonal antibody “cocktail” blocks COVID-19 variants: study
... University School of Medicine in St. Louis. In cell-culture studies, the researchers determined the ability of monoclonal ... Microbiology and Immunology at Vanderbilt. “We chose two antibodies to create a mixture that specifically would resist escape by ...
sommers - 03/08/2021 - 8:39am
-
VUMC-led team isolates antibody that blocks bird flu
... transmitted from birds to humans. In the journal Cell Host & Microbe , James Crowe Jr., MD, and colleagues report that human monoclonal antibodies, isolated from two survivors of H7N9 infections and produced in bulk in the laboratory, ...
sommers - 12/16/2019 - 10:57am
-
A protein that can melt tumors discovered at Vanderbilt
... gene expression programs through interaction with Host Cell Factor-1,” was published in the journal eLIFE on Jan. 8. ... activate genes. Protein transcription factors only need two domains: a DNA binding domain and an activation domain that spurs DNA ...
sommers - 02/01/2021 - 10:02am
-
New tool may speed antibody, vaccine research
... and validation of LIBRA-seq, which stands for Linking B-cell Receptor to Antigen Specificity through sequencing, was described recently ... The team is hopeful that LIBRA-seq will be a transformative technology that will have a direct impact on both basic and applied research. ...
sommers - 12/16/2019 - 3:04pm
-
Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease
... dexterity and the sense of touch in the hands and feet. Over two decades, Sanders has been studying a targeted approach to treat ... a protein that snakes through the lipid bilayer of the cell several times until it reaches the cell surface. Under disease conditions, ...
sommers - 10/30/2020 - 12:43pm
-
Widely used software, developed by Young Lab, tops 1,000 academic licenses
... understand metabolic diseases or improve the productivity of cell-based bioprocesses. “We developed it to serve our own research ... said Masood Ahammed Machingal, manager, digital technology licensing Building on the successes of non-patented intellectual ...
sommers - 05/03/2021 - 10:24am
-
PinPtr and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant
09/10/2015 Two Vanderbilt technologies, PinPtr (high-precision, low-cost GPS cloud ... Science Foundation Accelerating Innovation Research - Technology Translation (AIR-TT) grant of approximately $200,000 (each). PinPtr ... The AIR-TT solicitation supports research to overcome technology barriers/knowledge gaps in the translation of NSF-funded fundamental ...
steelmk - 10/02/2015 - 10:45am